Discounted Cash Flow
Medifast Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $274.5m | $17.8m | $22.5m | 6.5% | $1.51 |
| 2017 | $301.6m (9.8%) | $27.7m (55.4%) | $40.0m (78.0%) | 9.2% (41.5%) | $2.32 (53.6%) |
| 2018 | $501.0m (66.1%) | $55.8m (101.3%) | $55.9m (39.7%) | 11.1% (21.1%) | $4.67 (101.3%) |
| 2019 | $713.7m (42.4%) | $77.9m (39.7%) | $74.2m (32.8%) | 10.9% (-2.0%) | $6.62 (41.8%) |
| 2020 | $934.8m (31.0%) | $102.9m (32.0%) | $139.3m (87.7%) | 11.0% (0.8%) | $8.74 (32.0%) |
| 2021 | $1.5b (63.2%) | $164.0m (59.5%) | $60.3m (-56.7%) | 10.7% (-2.3%) | $14.01 (60.3%) |
| 2022 | $1.6b (4.8%) | $143.6m (-12.5%) | $177.9m (194.8%) | 9.0% (-16.4%) | $12.82 (-8.5%) |
| 2023 | $1.1b (-32.9%) | $99.4m (-30.8%) | $141.2m (-20.6%) | 9.3% (3.3%) | $9.13 (-28.8%) |
| 2024 | $602.5m (-43.8%) | $2.1m (-97.9%) | $17.0m (-87.9%) | 0.3% (-96.3%) | $0.19 (-97.9%) |
| 2025 | $385.8m (-36.0%) | $-18.7m (-993.0%) | $1.2m (-92.7%) | -4.8% (-1494.5%) | $-1.70 (-994.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.